Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma

Leukemia Research - Tập 34 - Trang 677-681 - 2010
Sophie L. Corthals1, Mojca Jongen-Lavrencic1, Yvonne de Knegt1, Justine K. Peeters1, H. Berna Beverloo2, Henk M. Lokhorst3, Pieter Sonneveld1
1Department of Hematology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands
2Department of Clinical Genetics, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands
3Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands

Tài liệu tham khảo

Kyle, 2004, Multiple myeloma, N Engl J Med, 351, 1860, 10.1056/NEJMra041875

Facon, 2001, Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy, Blood, 97, 1566, 10.1182/blood.V97.6.1566

Shaughnessy, 1999, Chromosome 13 deletion in myeloma, Curr Top Microbiol Immunol, 246, 199, 10.1007/978-3-642-60162-0_25

Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Schaffer, 2005

van Zutven, 2004, Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia, Haematologica, 89, 671

Dohner, 2000, Genomic aberrations and survival in chronic lymphocytic leukemia, N Engl J Med, 343, 1910, 10.1056/NEJM200012283432602